Diana Lüftner
- Oncology top 2%
- Molecular Biology
- Pulmonary and Respiratory Medicine top 5%
- Radiology, Nuclear Medicine and Imaging top 5%
- Cancer Research top 5%
- Co-authors
- K. PossingerKurt PossingerC. JehnBernd FlathMarcus ReifFlorian StrasserGernot ErnstWinfried Meißner
- Topics
- Advanced Breast Cancer Therapies (72 papers)HER2/EGFR in Cancer Research (63 papers)Breast Cancer Treatment Studies (46 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Diana Lüftner
160 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 114
- Oncology 1.4k
- Molecular Biology 547
- Pulmonary and Respiratory Medicine 523
- Radiology, Nuclear Medicine and Imaging 489
- Cancer Research 400
Countries citing papers authored by Diana Lüftner
This map shows the geographic impact of Diana Lüftner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Diana Lüftner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Diana Lüftner more than expected).
Fields of papers citing papers by Diana Lüftner
This network shows the impact of papers produced by Diana Lüftner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Diana Lüftner. The network helps show where Diana Lüftner may publish in the future.
Co-authorship network of co-authors of Diana Lüftner
This figure shows the co-authorship network connecting the top 25 collaborators of Diana Lüftner. A scholar is included among the top collaborators of Diana Lüftner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Diana Lüftner. Diana Lüftner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 7 | |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 4 | |
| 9 | 9 | |
| 10 | 19 | |
| 11 | 4 | |
| 12 | 0 | |
| 13 | 2 | |
| 14 | 7 | |
| 15 | 43 | |
| 16 | 3 | |
| 17 | 115 | |
| 18 | Serum HER-2/neu as a prediction and monitoring parameter in a phase II study with weekly paclitaxel in metastatic breast cancer. | 19 |
| 19 | Lack of HER-2/neu overexpression in non-Hodgkin's lymphoma. | 3 |
| 20 | 33 |
About Diana Lüftner
Diana Lüftner is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 176 papers that have together received 2.4k indexed citations. Recurring topics across this work include Advanced Breast Cancer Therapies (72 papers), HER2/EGFR in Cancer Research (63 papers) and Breast Cancer Treatment Studies (46 papers). The work is most often cited by research in Oncology (1.4k citations), Cancer Research (400 citations) and Biological Psychiatry (61 citations). Diana Lüftner has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include K. Possinger, Kurt Possinger, C. Jehn, Bernd Flath, Marcus Reif, Florian Strasser, Gernot Ernst, Winfried Meißner, Martin Schnelle and Thomas Ruhstaller. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.